Pyxis Oncology reported total assets of $54.92M and total liabilities of $43.48M for the quarter ended Jun 2026, down 59.6% year over year. This balance sheet covers 23 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 142.47M | 133.48M | 274.74M | 247.09M | 223.35M | 198.54M | 179.29M | 53.06M | 25.90M | 14.71M | 9.66M | 27.97M | 25.07M | 12.06M | 19.47M | 12.76M | 10.73M | 8.92M | 15.42M | 18.86M | |||
| Short-term InvestmentsInvestments (Current) | 1.47M | 1.47M | 1.47M | 1.47M | 1.47M | 96.29M | 116.77M | 118.25M | 109.63M | 129.06M | 130.65M | 132.76M | 107.46M | 92.67M | 78.21M | 67.34M | 51.44M | 14.14M | |||||
| Cash & Current Investments | 142.47M | 133.48M | 276.21M | 248.56M | 224.83M | 200.01M | 180.76M | 149.35M | 142.66M | 132.97M | 119.30M | 157.03M | 155.72M | 144.82M | 126.93M | 105.43M | 88.94M | 76.26M | 66.86M | 33.00M | |||
| Receivables - NetNet Receivables | 8.00M | 3.00M | |||||||||||||||||||||
| Receivables - OtherOther Receivables | 0.60M | 0.02M | |||||||||||||||||||||
| Receivables | 8.00M | 3.00M | |||||||||||||||||||||
| Prepaid Assets | 0.86M | 2.47M | 2.70M | 1.77M | 2.80M | 5.85M | 5.36M | 5.17M | 4.66M | 3.83M | 5.88M | 3.84M | 2.58M | 4.04M | 4.97M | 6.54M | 5.34M | 3.78M | 2.27M | ||||
| Current Assets | 134.34M | 278.67M | 251.26M | 226.59M | 202.81M | 186.61M | 156.18M | 149.30M | 139.09M | 124.60M | 172.38M | 161.04M | 148.87M | 132.44M | 111.87M | 99.96M | 83.07M | 72.11M | 36.73M | ||||
| Non-Current Assets | |||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 1.15M | 1.01M | 0.99M | 0.96M | 6.39M | 11.16M | 13.16M | 12.64M | 12.18M | 11.87M | 11.33M | 11.07M | 10.40M | 9.90M | 9.40M | 8.92M | 8.46M | 8.00M | 7.24M | ||||
| Intangibles | 22.29M | 24.46M | 23.73M | 23.68M | 23.62M | 23.87M | 2.54M | 2.49M | 2.43M | 2.90M | |||||||||||||
| Goodwill & Intangibles | 22.29M | 24.46M | 23.73M | 23.68M | 23.62M | 23.87M | 2.54M | 2.49M | 2.43M | 2.90M | |||||||||||||
| Long-Term Deferred Tax | 61.49M | 127.12M | |||||||||||||||||||||
| Other Non-Current Assets | 0.11M | 0.11M | 0.11M | 1.58M | 1.47M | 1.47M | |||||||||||||||||
| Non-Current Assets | 5.15M | 1.35M | 1.44M | 15.97M | 21.09M | 24.77M | 26.62M | 25.93M | 47.60M | 49.12M | 47.84M | 47.35M | 46.44M | 24.74M | 24.00M | 23.26M | 22.53M | 19.41M | 18.19M | ||||
| Assets | 139.49M | 280.02M | 252.70M | 242.56M | 223.90M | 211.38M | 182.80M | 175.23M | 186.69M | 173.73M | 220.22M | 208.39M | 195.31M | 157.18M | 135.87M | 123.22M | 105.60M | 91.52M | 54.92M | ||||
| Liabilities | |||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||
| Accounts Payables | 1.93M | 11.95M | 2.06M | 7.82M | 5.51M | 7.10M | 4.03M | 1.30M | 3.31M | 3.90M | 2.29M | 5.47M | 4.87M | 4.86M | 2.85M | 9.41M | 9.76M | 10.88M | 3.27M | ||||
| Notes Payables | 9.12M | ||||||||||||||||||||||
| Payables | 11.05M | 11.95M | 2.06M | 7.82M | 5.51M | 7.10M | 4.03M | 1.30M | 3.31M | 3.90M | 2.29M | 5.47M | 4.87M | 4.86M | 2.85M | 9.41M | 9.76M | 10.88M | 3.27M | ||||
| Accumulated Expenses | 5.46M | 6.59M | 17.13M | 7.10M | 13.59M | 24.54M | 6.36M | 7.39M | 16.63M | 12.97M | 10.83M | 10.09M | 14.06M | 11.37M | 10.08M | 6.70M | 8.00M | 8.55M | 12.38M | ||||
| Other Accumulated Expenses | 2.38M | 17.41M | 6.59M | 6.37M | 4.00M | ||||||||||||||||||
| Current Leases | 0.33M | 0.17M | 1.21M | 0.53M | 1.20M | 1.23M | 1.02M | 1.39M | 1.45M | 1.51M | 1.57M | 1.63M | 1.69M | 1.82M | |||||||||
| Current Deferred Revenue | 7.20M | 7.66M | |||||||||||||||||||||
| Total Current Liabilities | 16.84M | 18.71M | 19.19M | 14.92M | 19.09M | 31.63M | 11.60M | 9.22M | 28.33M | 25.76M | 14.14M | 16.90M | 20.32M | 17.68M | 14.43M | 17.68M | 19.38M | 21.13M | 27.47M | ||||
| Non-Current Liabilities | |||||||||||||||||||||||
| Capital Leases | 0.14M | 0.12M | 0.10M | 0.08M | 0.06M | 0.04M | 0.02M | ||||||||||||||||
| Preferred Stock Liabilities | 172.08M | 172.08M | |||||||||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 3.67M | 2.16M | 2.16M | 2.16M | 2.16M | ||||||||||||||||||
| Operating Leases | 15.68M | 16.05M | 18.92M | 19.04M | 20.73M | 20.41M | 20.10M | 19.76M | 19.40M | 19.03M | 18.65M | 18.25M | 17.83M | 17.40M | 16.96M | 16.01M | |||||||
| Other Non-Current Liabilities | 0.07M | ||||||||||||||||||||||
| Total Non-Current Liabilities | 16.84M | 18.71M | 19.19M | 30.60M | 35.15M | 50.55M | 29.95M | 48.75M | 48.02M | 36.06M | 38.59M | 41.63M | |||||||||||
| Total Liabilities | 57.59M | 16.90M | 18.71M | 19.19M | 30.60M | 35.15M | 50.55M | 30.64M | 29.95M | 48.75M | 48.02M | 36.06M | 38.59M | 41.63M | 36.43M | 32.76M | 35.57M | 36.83M | 38.11M | 43.48M | |||
| Shareholder's Equity | |||||||||||||||||||||||
| Total Debt | 9.12M | ||||||||||||||||||||||
| Common Equity | -57.59M | -71.44M | 261.31M | 233.51M | 211.97M | 188.75M | 160.82M | 152.16M | 145.28M | 137.95M | 125.70M | 184.16M | 169.79M | 153.68M | 120.75M | 103.10M | 87.64M | 68.78M | 53.41M | 11.44M | |||
| Liabilities and Shareholders Equity | 139.49M | 280.02M | 252.70M | 242.56M | 223.90M | 211.38M | 182.80M | 175.23M | 186.69M | 173.73M | 220.22M | 208.39M | 195.31M | 157.18M | 135.87M | 123.22M | 105.60M | 91.52M | 54.92M | ||||
| Retained Earnings | -74.90M | 353.00M | 356.58M | 360.59M | 365.05M | 373.23M | 383.11M | 392.90M | 408.63M | 411.82M | 473.64M | 476.62M | 481.25M | 484.08M | 487.71M | 490.65M | 493.72M | 496.47M | 503.18M | ||||
| Treasury Shares | 127.54M | 127.54M | 3.41M | 3.30M | 2.96M | 2.76M |